Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group

Ann Oncol. 2010 Aug;21(8):1730-1731. doi: 10.1093/annonc/mdq300. Epub 2010 Jun 7.

Authors

A Matakidou¹, K Mutsvangwa¹, W Ansell¹, L Lim¹, T B Powles¹, R T Oliver¹, J Shamash²

Affiliations

¹ Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
² Department of Medical Oncology, St Bartholomew's Hospital, London, UK. Electronic address: Jonathan.Shamash@bartsandthelondon.nhs.uk.

PMID: 20530199
DOI: 10.1093/annonc/mdq300

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antineoplastic Agents / pharmacokinetics
Antineoplastic Agents / therapeutic use*
Area Under Curve
Carboplatin / pharmacokinetics
Carboplatin / therapeutic use*
Clinical Trials as Topic*
Humans
Middle Aged
Neoplasm Metastasis
Prognosis
Remission Induction
Seminoma / drug therapy*
Seminoma / pathology

Substances

Antineoplastic Agents
Carboplatin